Immune checkpoint dysregulation refers to the abnormal functioning or expression of immune checkpoint proteins. In the context of cancer, this usually means that the mechanisms meant to keep the immune system in check are hijacked by tumor cells to avoid destruction. This dysregulation can be due to genetic mutations, epigenetic changes, or the tumor microenvironment influencing the expression of checkpoint molecules.
